Disclosed herein are
tricyclic compounds, including pyrimido[4′,5′:4,5]thieno[2,3-c]
pyridazine-8-amine, pyrido[3′,2′:4,5]thieno[3,2-d]
pyrimidine-4-amine, pyrazino[2′,3′:4,5]thieno[3,2-d]pyrimidin-4-amine, pyrido[3′,2′:4,5]furo[3,2-d]pyrimidin-4-amine, and pyrimido[4′,5′:4,5]furo[2,3-c]pyridazin-8-amine compounds, which may be useful as positive allosteric modulators of the
muscarinic acetylcholine receptor M4 (mAChR M4). Also disclosed herein are methods of making the compounds, pharmaceutical compositions comprising the compounds, and methods of treating neurological and psychiatric disorders associated with
muscarinic acetylcholine receptor dysfunction using the compounds and compositions.